Ginsenoside Rb1 [33], from P. notoginseng, has been reported to decrease the levels of p-STAT3 and SOCS3 in ovarian cancer cells, microglial cells, and obese mice. This evidence concerns the gene SOCS3 and ovarian carcinoma.